CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Chemotherapydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01807091
NCT01807091N/ACompleted
CompareCT.gov

Feasibility of Outpatient Induction Chemotherapy for Adult Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

University of Washington·interventional·Posted Mar 8, 2013·Updated Mar 5, 2021

In Brief

A clinical study evaluating Chemotherapy for Adult Acute Myeloid Leukemia and Adult Myelodysplastic Syndrome. Completed, enrolled 17 participants across 9 sites.

Detailed Summary

This pilot clinical trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) or advanced myelodysplastic syndrome (MDS), at least 18 years of age will be examined. Treating eligible patients with induction chemotherapy in an outpatient setting may save in healthcare cost and improve a patients' quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdult Acute Myeloid Leukemia, Adult Myelodysplastic Syndrome
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 8, 2013
Enrollment StartMay 21, 2013
Primary CompletionJan 8, 2020
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 13.3 years ago

Interventions

Chemotherapydrug

Receive outpatient induction chemotherapy